Sumitomo Corporation Europe and existing investor Tekfen Ventures helped provide $28.5m for the gene-edited crop developer's latest round.

UK-based crop provider Tropic Biosciences closed a $28.5m series B round today featuring conglomerates Sumitomo and Tekfen, which invested through Sumitomo Corporation Europe and Tekfen Ventures respectively. Temasek led the round, which included Genoa Ventures, Agronomics, Skyviews Life Science, Pontifax AgTech, Five Seasons Ventures, Emerald Technology Ventures, Bits x Bites and the UK Science &…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.